STOCK TITAN

Kamada director granted 30,000 stock options

Kamada Ltd director Lilach Payorski received an employee stock option grant on August 5, 2026 for 30,000 options, each exercisable into one ordinary share at an exercise price of $7.52 per share, converted from NIS.

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Kamada Ltd director Lilach Payorski received an employee stock option grant on August 5, 2026 for 30,000 options, each exercisable into one ordinary share at an exercise price of $7.52 per share, converted from NIS. The options vest in four equal annual installments over four years, are exercisable for 10 years, and are held indirectly by a trustee under the company’s 2011 Share Award Plan, leaving Payorski with 30,000 options after this award.

Positive

  • None.

Negative

  • None.
Insider Payorski Lilach
Role Director
Type Security Shares Price Value
Grant/Award Employee Stock Option (right to buy) F1, F2, F3 30,000 $0.00 $0.00
Holdings After Transaction: Employee Stock Option (right to buy) — 30,000 contracts (Indirect, Held by trustee)
Footnotes (3)
  1. F1. The exercise price presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of August 4, 2026.
  2. F2. The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.
  3. F3. Held by trustee under the Company's 2011 Share Award Plan.
Options granted 30,000 options Employee stock option grant to director Lilach Payorski on August 5, 2026
Exercise price $7.52 per share Exercise price in U.S. dollars, convenience conversion from NIS as of August 4, 2026
Underlying ordinary shares 30,000 shares Each option is exercisable into one ordinary share of Kamada Ltd
Vesting period 4 years Options vest in four equal installments of 25% on each anniversary of the grant date
Option term 10 years Options are exercisable for 10 years from grant; unexercised options expire immediately thereafter
Post-grant derivative holdings 30,000 options Total employee stock options held indirectly following this grant
Employee Stock Option financial
"security_title: "Employee Stock Option (right to buy)""
An employee stock option is a promise that lets a worker buy company shares later at a predetermined price, often after they stay for a certain period or meet performance goals — think of it like a coupon that locks in today's price for a future purchase. It matters to investors because options align employees’ incentives with company performance, can increase the number of shares outstanding (dilution) when exercised, and represent a compensation cost that affects reported profits and shareholder value.
exercise price financial
"The exercise price presented in U.S. dollars represent a convenience conversion"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest over a period of four years financial
"The options will vest over a period of four years in four equal installments"
Held by trustee financial
"Held by trustee under the Company's 2011 Share Award Plan."
Share Award Plan financial
"Held by trustee under the Company's 2011 Share Award Plan."
indirect financial
"ownership_type: "indirect" with nature_of_ownership "Held by trustee""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Kamada (KMDA) disclose for Lilach Payorski?

Kamada disclosed that director Lilach Payorski received an employee stock option grant for 30,000 options on August 5, 2026. Each option is exercisable into one ordinary share at an exercise price of $7.52 per share, with vesting over four years and a 10-year term.

How many Kamada (KMDA) shares are covered by Lilach Payorski’s new options?

The grant covers 30,000 underlying ordinary shares of Kamada. Each employee stock option allows purchase of one ordinary share, giving Payorski indirect rights, via a trustee, to acquire up to 30,000 shares if the options vest and are exercised within the 10-year term.

What is the exercise price of Lilach Payorski’s Kamada (KMDA) stock options?

The options have an exercise price of $7.52 per share, shown in U.S. dollars as a convenience conversion from NIS. This price applies to each of the 30,000 options granted and is relevant if Payorski chooses to exercise the options after vesting.

How do Lilach Payorski’s Kamada (KMDA) options vest and when do they expire?

The options vest over four years in four equal installments, with 25% vesting on each anniversary of the grant date. They are exercisable for 10 years from the grant date, after which any unexercised options will expire immediately.

How are Lilach Payorski’s Kamada (KMDA) options held and classified?

The options are reported as indirectly owned and are held by a trustee under Kamada’s 2011 Share Award Plan. Following this award, Payorski’s reported derivative holdings from this grant total 30,000 employee stock options linked to ordinary shares.

Were Lilach Payorski’s Kamada (KMDA) option grants under a Rule 10b5-1 plan?

The filing’s Rule 10b5-1 checkbox is not marked as applicable, indicating the reported option grant was not affirmed as executed under a Rule 10b5-1 trading plan. The transaction is described as a grant or award acquisition of derivative securities.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Payorski Lilach

(Last)(First)(Middle)
2 HOLTZMAN ST.

(Street)
REHOVOT

(City)(State)(Zip)

ISRAEL

(Country)
2. Issuer Name and Ticker or Trading Symbol
KAMADA LTD [ KMDA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/05/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (right to buy)$7.52(1)08/05/2026A30,000 (2) (2)Ordinary Shares30,000$0.0030,000IHeld by trustee(3)
Explanation of Responses:
1. The exercise price presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of August 4, 2026.
2. The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.
3. Held by trustee under the Company's 2011 Share Award Plan.
/s/ Lilach Payorski08/06/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading